Lunec, J.
322  results:
Search for persons X
?
4

What drives development of HCC in non-cirrhotic NAFLD?:

Mahdi, A. ; Zaki, M. ; Lunec, J....
Journal of Hepatology.  68 (2018)  - p. S49 , 2018
 
?
 
?
7

442 Triarylpyrroles, dual inhibitors of the MDM2-p53 and MD..:

Blackburn, T. ; Ahmed, H. ; Coxon, C.R....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 139-140 , 2010
 
?
8

545 Expression of methylthioadenosine phosphorylase (MTAP) ..:

Abdul Razak, A. ; Nutt, J. ; O'Toole, K....
European Journal of Cancer Supplements.  8 (2010)  7 - p. 173 , 2010
 
?
9

Multicenter study to assess potential hazards from exposure..:

Williams, G.M. ; Caldwell, J. ; Armstrong, D....
Regulatory Toxicology and Pharmacology.  53 (2009)  2 - p. 107-120 , 2009
 
?
12

Histological profile of tumours fromMYCNtransgenic mice:

Moore, H C ; Wood, K M ; Jackson, M S...
Journal of Clinical Pathology.  61 (2008)  10 - p. 1098-1103 , 2008
 
?
13

437 POSTER MDM2 and MDMX status as a determinant of in vitr..:

Lu, X. ; Liu, J. ; Watson, A....
European Journal of Cancer Supplements.  6 (2008)  12 - p. 137 , 2008
 
?
14

Reactive oxygen species modify human DNA, eliciting a more ..:

BLOUNT, S ; GRIFFITHS, H ; EMERY, P.
Clinical and Experimental Immunology.  81 (2008)  3 - p. 384-389 , 2008
 
1-15